Literature DB >> 34767276

Gut microbiota and vitamin status in persons with obesity: A key interplay.

Lise Voland1, Tiphaine Le Roy1, Jean Debédat1, Karine Clément1,2.   

Abstract

There are numerous factors involved in obesity progression and maintenance including systemic low-grade inflammation, adipose tissue dysfunction, or gut microbiota dysbiosis. Recently, a growing interest has arisen for vitamins' role in obesity and related disorders, both at the host and gut bacterial level. Indeed, vitamins are provided mostly by food, but some, from the B and K groups in particular, can be synthesized by the gut bacterial ecosystem and absorbed in the colon. Knowing that vitamin deficiency can alter many important cellular functions and lead to serious health issues, it is important to carefully monitor the vitamin status of patients with obesity and potentially already existing comorbidities as well as to examine the dysbiotic gut microbiota and thus potentially altered bacterial metabolism of vitamins. In this review, we examined both murine and human studies, to assess the prevalence of sub-optimal levels of several vitamins in obesity and metabolic alterations. This review also examines the relationship between vitamins and the gut microbiota in terms of vitamin production and the modulation of the gut bacterial ecosystem in conditions of vitamin shortage or supplementation. Furthermore, some strategies to improve vitamin status of patients with severe obesity are proposed within this review.
© 2021 World Obesity Federation.

Entities:  

Keywords:  biotin; gut microbiota; obesity; vitamins

Mesh:

Substances:

Year:  2021        PMID: 34767276     DOI: 10.1111/obr.13377

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  3 in total

1.  Polydextrose Alleviates Adipose Tissue Inflammation and Modulates the Gut Microbiota in High-Fat Diet-Fed Mice.

Authors:  Qiuyue Hu; Yixin Niu; Yanxia Yang; Qianyun Mao; Yao Lu; Hui Ran; Hongmei Zhang; Xiaoyong Li; Hongxia Gu; Qing Su
Journal:  Front Pharmacol       Date:  2022-02-02       Impact factor: 5.810

Review 2.  Synbiotic Supplements in the Prevention of Obesity and Obesity-Related Diseases.

Authors:  Emília Hijová
Journal:  Metabolites       Date:  2022-03-31

3.  Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics.

Authors:  Svenja Sydor; Christian Dandyk; Johannes Schwerdt; Paul Manka; Dirk Benndorf; Theresa Lehmann; Kay Schallert; Maximilian Wolf; Udo Reichl; Ali Canbay; Lars P Bechmann; Robert Heyer
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.